학술논문
Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Document Type
Article
Author
Source
In Clinical Breast Cancer 2009 9(1):23-28
Subject
Language
ISSN
1526-8209